SSVEP Evaluation of Brain Function (PRO)

Sponsor
Headsafe MFG (Industry)
Overall Status
Recruiting
CT.gov ID
NCT06013566
Collaborator
(none)
1,000
1
36
27.8

Study Details

Study Description

Brief Summary

The investigational device used in this clinical investigation, the Nurochek PRO System (NCPRO), is a portable electroencephalogram (EEG) headset which delivers a visual stimulus and measures a VEP. The visual stimulus is delivered to the subjects' eyes via light-emitting diodes, and the EEG measures the user's visual-evoked potential. This headset communicates with an application on a computer, which processes the signals and transmits them to a secure cloud server for analysis and storage of the data. Nurochek PRO is a development of the previously FDA cleared Nurochek System.

The primary objective of this clinical investigation was to evaluate the performance of the investigational device (NCPRO) against clinical diagnosis of detection of mild traumatic brain injury (mTBI). The primary endpoint outlined for this study was set at the collection of 100 valid investigational device readings from individuals with concussion and 500 valid investigational device readings from healthy individuals who have had a plausible mechanism of sustaining a concussion, but do not have one. Additionally, readings from healthy individuals are also to be acquired.

The aim of this study was to collect data from 100 readings from individuals with concussion. The initial assumption was that sites would provide players pre-season and make players available for testing post-concussion. In practice, some sites provided player data only post-concussion event (such as medical clinics). Participants were acquired from sporting clubs, medical clinicals and schools.

Condition or Disease Intervention/Treatment Phase
  • Device: SSVEP

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
SSVEP Evaluation of Brain Function (PRO)
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2026
Anticipated Study Completion Date :
Jan 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Baseline

This cohort contains individuals tested at baseline, usually in the pre-season of their sporting season

Device: SSVEP
Non-invasive, non-interventional SSVEP EEG device
Other Names:
  • Nurochek PRO
  • Concussed

    This cohort contains individuals who have had a concussion, diagnosed by a doctor.

    Device: SSVEP
    Non-invasive, non-interventional SSVEP EEG device
    Other Names:
  • Nurochek PRO
  • Suspected Concussion

    This cohort contains individuals suspected of having a concussion, but were cleared by a medical professional and do not have a concussion.

    Device: SSVEP
    Non-invasive, non-interventional SSVEP EEG device
    Other Names:
  • Nurochek PRO
  • Outcome Measures

    Primary Outcome Measures

    1. Steady State Visual Evoked Potential [5 days]

      A measure of the steady state visual evoked potential (SSVEP) from the device and comparison with a Doctor's diagnosis.

    Secondary Outcome Measures

    1. Recovery from m TBI [30 days]

      Follow up testing with the investigational device to examine of there is a link between mTBI recovery and investigational device recordings of brain activity.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Individuals aged 12 years and older, participating in sport-related activities.
    Exclusion Criteria:
    • Individuals are excluded if they have a history of seizures, history of epilepsy, structural brain injuries, legal blindness, or sensitivity to flashing lights.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Headsafe Sydney Australia

    Sponsors and Collaborators

    • Headsafe MFG

    Investigators

    • Principal Investigator: Craig Donaldson, MBBS, Principal Investigator

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Headsafe MFG
    ClinicalTrials.gov Identifier:
    NCT06013566
    Other Study ID Numbers:
    • 2018-10-891-PRO
    First Posted:
    Aug 28, 2023
    Last Update Posted:
    Aug 28, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Headsafe MFG
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 28, 2023